Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Idogen AB | 1,783,907 | net | 16 Jan 2023 | tx 20+1,783,915−8 |
| Elicera Therapeutics AB | 122,900 | net | 11 Mar 2025 | tx 6+122,900 |
| IDOGEN | 2,891 | net | 27 Dec 2017 | tx 1+2,891 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Mar 2025 | PURCHASE | Elicera Therapeutics AB | 51,600 | 1.85 SEK | |
| 10 Mar 2025 | PURCHASE | Elicera Therapeutics AB | 18,000 | 0.50 SEK | derivfirst after silence |
| 08 Mar 2024 | PURCHASE | Elicera Therapeutics AB | 4,800 | 16.20 SEK | first after silence |
| 16 Jan 2023 | PURCHASE | Idogen AB | 1,048,149 | 0.20 SEK | |
| 21 Jun 2022 | PURCHASE | Idogen AB | 250,000 | 0.04 SEK | deriv |
| 10 Feb 2022 | PURCHASE | Idogen AB | 82,680 | 3.06 SEK | |
| 05 Oct 2021 | PURCHASE | Idogen AB | 43,000 | 2.06 SEK | |
| 05 Oct 2021 | PURCHASE | Idogen AB | 43,000 | 2.06 SEK | |
| 05 Jul 2021 | PURCHASE | Elicera Therapeutics AB | 23,500 | 4.30 SEK | |
| 22 Jun 2021 | PURCHASE | Idogen AB | 60,000 | 0.42 SEK | deriv |
| 10 Jun 2021 | GRANT_AWARD | Elicera Therapeutics AB | 12,500 | 8.00 SEK | |
| 10 Jun 2021 | GRANT_AWARD | Elicera Therapeutics AB | 12,500 | 0.00 SEK | deriv |
| 01 Dec 2020 | PURCHASE | Idogen AB | 43,000 | 3.75 SEK | |
| 15 Jun 2020 | PURCHASE | Idogen AB | 30,000 | 0.56 SEK | deriv |
| 16 Mar 2020 | PURCHASE | Idogen AB | 92,000 | 0.60 SEK | first after silence |
| 05 Dec 2018 | PURCHASE | Idogen AB | 38,330 | 1.75 SEK | |
| 27 Dec 2017 | PURCHASE | IDOGEN | 2,891 | 4.39 SEK | |
| 28 Dec 2017 | PURCHASE | Idogen AB | 3,391 | 0.27 SEK | anomaly |
| 28 Dec 2017 | PURCHASE | Idogen AB | 3,391 | 0.62 SEK | |
| 05 Jul 2017 | PURCHASE | Idogen AB | 200 | 6.00 SEK | anomaly |
| 12 Jun 2017 | PURCHASE | Idogen AB | 687 | 42.00 SEK | |
| 19 Jun 2017 | PURCHASE | Idogen AB | 1,200 | 42.00 SEK | |
| 12 Jun 2017 | SALE | Idogen AB | 4 | 0.20 SEK |
3 purchases reported after at least 12 months of silence — most recent on 10 Mar 2025.